Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy

Tafamidis meglumine, a transthyretin (TTR) stabilizer, is effective in delaying the progression of neuropathy in TTR amyloidosis with Val30Met mutations. However, its efficacy in TTR amyloid cardiomyopathy is not fully elucidated. Herein, we report a 73‐year‐old Japanese man with a diagnosis of TTR...

Descripción completa

Detalles Bibliográficos
Autores principales: Shintani, Yasuhiro, Okada, Atsushi, Morita, Yoshiaki, Hamatani, Yasuhiro, Amano, Masashi, Takahama, Hiroyuki, Amaki, Makoto, Hasegawa, Takuya, Ohta‐Ogo, Keiko, Kanzaki, Hideaki, Ishibashi‐Ueda, Hatsue, Yasuda, Satoshi, Shimazaki, Chihiro, Yoshinaga, Tsuneaki, Yazaki, Masahide, Sekijima, Yoshiki, Izumi, Chisato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352892/
https://www.ncbi.nlm.nih.gov/pubmed/30478886
http://dx.doi.org/10.1002/ehf2.12382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352892/
https://www.ncbi.nlm.nih.gov/pubmed/30478886
http://dx.doi.org/10.1002/ehf2.12382

Ejemplares similares